Popular on eTradeWire
- Stephanie Peppers Launches Rethread Chronicles - 176
- Celebrate National Direct Support Recognition Week, September 8 – 14, 2024 - 143
- Cozy Up with Adirondack Fragrance Farm's New Soy Wax Melts - 115
- History Matters: Book Recommendations for September 2024 - 112
- Allegiant Management Group Launches New Website Following Recent Rebranding - 101
- Atlas Elite Entertainment Releases New Single "Forever"
- Mounts Botanical Garden to Present RIBBIT THE EXHIBIT II with 18 Larger-Than-Life Frog Sculptures
- Wagoner Roofing Launches New Website
- Title Alliance Announces Strategic Consolidation of their Arizona Joint Ventures to Enhance Business
- Colony Ridge Welcomes A Second DG Market!
Similar on eTradeWire
- Hypothesis by Richard H. Davis: Carrier Pigeons and Milk Immunity
- IGC Pharma Wins 2 Awards in Phase 1 of NIA's AI PREPARE Challenge, Advancing Alzheimer's Early Prediction Research
- Terumo Blood and Cell Technologies and Nova Biomedical collaborate on automated cell culture sensing
- AI Team from "PersonalAIze" Expert Assessment; Groundbreaking AI Platform Starting with Early Cancer Detection: Renovaro; Stock Symbol: RENB
- Bioasis Announces Resignation of Board of Directors
- Elevation Strategic Development, LLC Expands with New Subsidiary and Enhanced Service Offerings
- NRx Pharmaceuticals NRXP: Prominently Featured in Psychiatrist.com; Article Titled "How NRx Could Upend the Fight Against Depression and Suicide"
- Creative Biolabs presents codes ruling antibody discovery
- Planned Spin-Out to Focus on Gene Therapy for Type 1 and 2 Diabetes in Parallel to Treatments for Late Stage Lung Cancer: Genprex: Stock Symbol: GNPX
- Logical Biological appoints Stephane Argivier as new CEO
CD BioSciences' mRNA Display Technology Enables High-Throughput In Vitro Screening
eTradeWire News/10779558
NEW YORK - eTradeWire -- CD BioSciences, a leading biotechnology company, is revolutionizing in vitro screening with its advanced mRNA display (https://www.aspiregene.com/) technology. This innovative technology allows for high-throughput screening of protein, antibody, as well as peptide libraries, leading to faster and more accurate results in drug discovery and development.
mRNA display technology, also known as mRNA-protein fusion display technology, is an in vitro polypeptide/protein screening technology that fuses genotype (mRNA) and phenotype (protein) and can be used for the discovery and interaction analysis of biomolecular ligands. As traditional methods of screening molecule libraries can be time-consuming and labor-intensive, often resulting in limited success rates, CD BioSciences' multi-molecular discovery platform based on mRNA display technology solves these challenges by enabling rapid screening of large libraries of proteins, antibodies, and peptides in a highly efficient and cost-effective manner.
More on eTradeWire News
"With our mRNA display technology, we are able to screen thousands of protein variants simultaneously, allowing for the identification of potential drug candidates much faster than traditional methods," said a spokesperson for CD BioSciences. "This technology has the potential to significantly accelerate the drug development process and improve success rates in identifying novel therapeutic targets."
CD BioSciences' high-throughput screening platform combines mRNA display with in vitro translation, selection, and amplification processes. This approach allows for the direct coupling of protein function with its encoding mRNA, enabling rapid screening of protein libraries with high sensitivity and specificity. The application of CD BioSciences's mRNA display technology is wide-ranging, from identifying novel drug targets to developing therapeutic antibodies and enzymes. By streamlining the screening process and increasing the success rates of drug discovery, this technology has the potential to revolutionize the biopharmaceutical industry.
More on eTradeWire News
As a leading service provider in drug development, CD BioSciences also drives forward drug discovery with biophysical assay (https://www.cd-biophysics.com/) technologies. Its team of scientists uses a variety of basic and sophisticated biophysical methods such as MicroScale Thermophoresis (MST), nano-scale Differential Scanning Fluorimetry (nanoDSF), and Isothermal Titration Calorimetry (ITC) to provide customers with data related to binding affinity, thermodynamics, and molecular parameters such as protein stability, unfolding, radius, polydispersity index and many more.
About CD BioSciences
CD BioSciences is a biotechnology company focused on developing innovative technologies and solutions for drug discovery and development. Depending upon its mRNA display and biophysical analysis technologies and experience, CD BioSciences can offer tailored service packages for a wide range of project types and scientific questions for all researchers working or interested in protein analysis, protein- and RNA-based drug discovery, or molecular interaction characterization.
mRNA display technology, also known as mRNA-protein fusion display technology, is an in vitro polypeptide/protein screening technology that fuses genotype (mRNA) and phenotype (protein) and can be used for the discovery and interaction analysis of biomolecular ligands. As traditional methods of screening molecule libraries can be time-consuming and labor-intensive, often resulting in limited success rates, CD BioSciences' multi-molecular discovery platform based on mRNA display technology solves these challenges by enabling rapid screening of large libraries of proteins, antibodies, and peptides in a highly efficient and cost-effective manner.
More on eTradeWire News
- AsInt Launches Core Calculator
- Apereo Foundation's Xerte Project turns 18!
- Join Us for Apereo's November Micro Conference Featuring Karen Sandler
- Local SF Conservatory Pre-College Student Selected to Perform at Carnegie Hall
- CU Aerospace, LLC Awarded Multi-Million Dollar Contract for Cutting-Edge Space Thruster
"With our mRNA display technology, we are able to screen thousands of protein variants simultaneously, allowing for the identification of potential drug candidates much faster than traditional methods," said a spokesperson for CD BioSciences. "This technology has the potential to significantly accelerate the drug development process and improve success rates in identifying novel therapeutic targets."
CD BioSciences' high-throughput screening platform combines mRNA display with in vitro translation, selection, and amplification processes. This approach allows for the direct coupling of protein function with its encoding mRNA, enabling rapid screening of protein libraries with high sensitivity and specificity. The application of CD BioSciences's mRNA display technology is wide-ranging, from identifying novel drug targets to developing therapeutic antibodies and enzymes. By streamlining the screening process and increasing the success rates of drug discovery, this technology has the potential to revolutionize the biopharmaceutical industry.
More on eTradeWire News
- CleanApps.com Launches Providing A Trusted Platform for Free, Safe Software Downloads and Tech News
- Affordable Braces in Allentown, PA: Exeter Smiles Offers Comprehensive Care at $3,995
- Who Is This Pirate Preacher—This Defender of the Homeless, Least, and Lost?
- Soft Water Nevada: The Leading Provider of RO Water Systems in Las Vegas
- Origination of Prince Oak's new alias and reasons of his change — the Eurasian Prince's newest nominal label is "Papa Eurasia"
As a leading service provider in drug development, CD BioSciences also drives forward drug discovery with biophysical assay (https://www.cd-biophysics.com/) technologies. Its team of scientists uses a variety of basic and sophisticated biophysical methods such as MicroScale Thermophoresis (MST), nano-scale Differential Scanning Fluorimetry (nanoDSF), and Isothermal Titration Calorimetry (ITC) to provide customers with data related to binding affinity, thermodynamics, and molecular parameters such as protein stability, unfolding, radius, polydispersity index and many more.
About CD BioSciences
CD BioSciences is a biotechnology company focused on developing innovative technologies and solutions for drug discovery and development. Depending upon its mRNA display and biophysical analysis technologies and experience, CD BioSciences can offer tailored service packages for a wide range of project types and scientific questions for all researchers working or interested in protein analysis, protein- and RNA-based drug discovery, or molecular interaction characterization.
Source: CD BioSciences
Filed Under: Biotech
0 Comments
Latest on eTradeWire News
- Watson Design announced as a distinguished Platinum Winner at the Design Skill Awards 2024
- The City Tutors Welcomes Brad Timmers as New Chief Technology Officer to Drive Tech Innovation
- SkyWash Drones Celebrates Successful Showcase at Healthcare Estates 2024 in Manchester
- Good Shepherd Ministries to serve 1500 Thanksgiving Meals
- $19 Million Jury Award for Passport 420 in Insurance Bad Faith Case
- NGAGE Intelligence Announces New Module for Microsoft Copilot
- Award-Winning USAF Band of Mid-America Indianapolis Concert 10/21
- Award-Winning USAF Band of Mid-America Announces Wisconsin Concerts November 9-13
- The Basketball Super League Announces the 2024/2025 Draft Combine-Your Gateway to Pro Basketball!
- Kiersten Sales on "Clay Mastermind": Insights from a Rising Star in Competitive Shooting
- Dream Foundation Hosts its Second Annual No Gala Gala
- Dawn Grant Welcomes Neil Chadwick on "Clay Mastermind": Exploring the Future of Shooting Sports
- Bug Busters Celebrates 40 Years in the Pest Control Industry
- "Join the Revolution: Dot & Lola's 'Liberation' Movement Challenges Toxic Beauty Norms."
- Invenio IT Partners with Vonahi Security to Offer Automated Network Penetration Testing for Enhanced Enterprise Security
- Made-in-the USA Manufacturer, Jeron Electronic Systems, has Experienced No Supply Delays for Shipping Nurse Call Systems and Area of Rescue Systems
- Startups in 2025 - guide to build a strong foundation
- City Phones Your Only Destination for Top Quality Smartphone Repair
- ESTAPPA Navigation Platform Corp. Highlights Market Expansion and Describes Its Unique Positioning
- National Minority Health Association and Cell-Ed Announce Upcoming Webinar: Empowering Caregivers Through Innovative Training Programs